Skip to main content

Intracranial Neoplasm clinical trials at UCSF
1 research study open to eligible people

  • Fluoroethyltyrosine in Detecting Tumors in Participants With Recurrent Intracranial Tumors

    open to eligible people ages 3 years and up

    This phase II trial studies how well F-18 fluoroethyltyrosine (fluoroethyltyrosine) works in detecting tumors in participants with intracranial tumors that have come back. Imaging agents, such as fluoroethyltyrosine, may help doctors see the tumor better during a positron emission tomography (PET) scan.

    San Francisco, California

Last updated: